Chronic lymphocytic thyroiditis and tumor-infiltrating lymphocytes combined in thyroid papillary carcinoma;Tiroid papiller karsinomlarinda kronik lenfositik tiroidit ve tümörü infiltre eden lenfosit birlikteliǧi

Turk Onkoloji Dergisi

Volumn 24, Issue 4, 2009, Pages 172-176

  Onak Kandemir, Nilüfer ^a   Barut, Figen ^a   Keser, Sevinç ^b   Karadayi, Nimet ^b   Bektaş, Sibel ^a   Doǧan Gün, Banu ^a   Bahadir, Burak ^a   Yurdakan, Gamze ^a   Özdamar, Şükrü Oǧuz ^a  

^a Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

^b HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Lymphocytic thyroiditis; Papillary carcinoma; Thyroid; Tumor infiltrating lymphocytes

Indexed keywords

ADULT; ARTICLE; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR ASSOCIATED LEUKOCYTE;

EID: 77953399742     PISSN: 13007467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Treseler PA, Clark OH. Prognostic factors in thyroid carcinoma. Surg Oncol Clin N Am 1997;6(3):555-98.
2. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999;84(2):458-63.
3. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98(1):31-40.
4. Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 2008; 15(5): 1518-22.
5. Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 2008;33(1):1-5.
6. Shu S, Plautz GE, Krauss JC, Chang AE. Tumor immunology. JAMA 1997;278(22): 1972-81.
7. Herberman RB. Role of natural killer cells and T cells in immune surveillance. Leuk Res 2000;24(9):775.
8. Herberman RB. Cancer immunotherapy with natural killer cells. Semin Oncol 2002;29(3 Suppl 7):27-30.
9. Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001;25(5):632-7.
10. Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL. Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004;130(7):819-24.
11. Kurukahvecioglu O, Taneri F, Yüksel O, Aydin A, Tezel E, Onuk E. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther 2007;24(3):510-6.
12. Bagnasco M, Venuti D, Paolieri F, Torre G, Ferrini S, Canonica GW. Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity. J Clin Endocrinol Metab 1989;69(4):832-6.
13. Lucas SD, Karlsson-Parra A, Nilsson B, Grimelius L, Akerström G, Rastad J, et al. Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. Hum Pathol 1996;27(12):1329-35.
14. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, et al. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 2001;86(3):1346-54.
15. Kuo SF, Chao TC, Hsueh C, Chuang WY, Yang CH, Lin JD. Prognosis and risk stratification in young papillary thyroid carcinoma patients. Endocr J 2008;55(2):269-75.
16. Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998;8(3):197-202.